Searched for
IPCA LABORATORIES RESULTS
PL Capital cuts Nifty target to 26,449, lists 16 high conviction stock picksAmidst global market turmoil from the Iran-US war and El Nino, PL Capital lowered its Nifty 50 target to 26,449. The brokerage anticipates ...- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...
- Laurus Labs adds Rs 40,150 crore to investors' wealth in a year with 120% rally. Buy, hold or book profits?Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...
- Big Movers on D-St: What should investors do with KEI Industries, Ipca Laboratories and GSFC?The Indian market closed higher on Wednesday, with S&P BSE Sensex up over 150 points and Nifty50 above 17800 levels. The buying was seen in...
- Ipca Labs Q2 results: Net profit declines 6% to Rs 250 croreThe board has "approved subdivision of every 1 equity share of the nominal/face value of Rs 2/ each into 2 equity shares of the nominal/fac...
- Zomato, IRCTC to find place in MSCI India Index; 2 other stocks to be removedMindtree and IRCTC, which have rallied 127 per cent and 144 per cent, respectively in the past six months, may see passive flows of Rs 1,50...
- MSCI likely to include 7 Indian stocks to its standard indexMSCI will announce the changes in constituents for the MSCI global standard indices on November 12. The final changes will take place on No...
- Ipca Labs Q1 results: Net profit declines 31% to Rs 307 croreConsolidated total income of the company stood at Rs 1,586.81 crore for the quarter under consideration.
- Buy Ipca Laboratories, target price Rs 1,774: Dharmesh ShahThe analyst suggested a stoploss at Rs 1625.
- US health regulator finds Silvassa unit non-compliant with CGMP: Ipca LabsThe company said that since this manufacturing facility is already under USFDA import alert and presently not doing any US business, this w...
- Buy Ipca Laboratories, target Rs 915: NomuraBuy Ipca Laboratories Ltd. at a price target of Rs 915.
- Ipca Lab tanks 16% intraday, trims most of early losses laterAfter plunging 16.27 per cent to Rs 560, its 52-week low on BSE during the day, the stock later saw some recovery and finally ended 2.02 pe...
- Ipca Labs gets warning letter from USFDA for 3 plantsIpca Laboratories has received warning letter from the US health regulator for three facilities on which the regulator had earlier imposed ...
- Ipca labs wins trademark case against Anrose PharmaIpca Laboratories accused Anrose Pharma of ‘passing-off’ , which in IPR law means making a false representation that is likely to force a p...
- Ipca Laboratories Q4 net profit at Rs 75.43 croreIt had posted a net profit of Rs 76.61 crore for the corresponding quarter of the previous fiscal, the company said in a statement.
- Ipca Labs reports Q3 net profit at Rs 88 croreIpca Labs posted a net profit of Rs 87.89 cr for Q3 on the back of strong sales across domestic and international markets.
- Arihant recommends 'Accumulate' on Ipca LaboratoriesArihant Capital Services has recommended to ‘Accumulate’ Ipca Laboratories even as the company’s fourth quarter results were “marginally be...
- Ipca Laboratories' NCD issue gets CRISIL 'AA-'CRISIL has assigned ‘AA-/Stable’ rating to Ipca Laboratories Ltd’s Rs 50 crore non-convertible debentures (NCDs).
- Ranbaxy ties up with Ipca LaboratoriesPharmaceutical major Ranbaxy on Thursday said it has entered into a strategic alliance with Mumbai-based Ipca Laboratories to develop gener...
Load More
